Ibrahim M

Louis A. Faillace, MD, Department of Psychiatry & Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas, USA.

3 papers · ORCID

ArticlePsilocybin

Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study.

Meyer TD, Vale LN, Ibrahim M +3

Europe PMC2026

ArticlePsilocybin

Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?

Vale LN, Ibrahim M, Fávaro-Pereira L +2

Europe PMC2026

ArticlePsilocybin

Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.

Meyer TD, Ibrahim M, Vale LN +1

Europe PMC2025